Literature DB >> 30831597

Relation of choline intake with blood pressure in the National Health and Nutrition Examination Survey 2007-2010.

Siraphat Taesuwan1,2, Francoise Vermeylen3, Marie A Caudill1, Patricia A Cassano1,4.   

Abstract

BACKGROUND: Dietary choline is a precursor of trimethylamine N-oxide (TMAO), a metabolite that has been associated with an increased risk of cardiovascular disease. The mechanism underlying this association is unknown, but may include TMAO effects on blood pressure (BP).
OBJECTIVES: This study assessed the association of choline intake with hypertension and BP in US adults through the use of NHANES 2007-2010 data.
METHODS: This cross-sectional study was conducted in nonpregnant individuals aged ≥20 y. Choline intake was assessed with the use of two 24-h recalls. Outcomes were BP and hypertension status, which was assessed through the use of questionnaires and BP measurements. Modifying factors (e.g., sex, race/ethnicity) and dietary compared with supplemental sources of choline intake were also investigated.
RESULTS: The associations of total (dietary + supplemental) and dietary choline intake with the prevalence odds of hypertension differed by sex (n = 9227; P-interaction = 0.04 and 0.03, respectively). In women, both total and dietary choline intake tended to be inversely associated with hypertension (n = 4748; prevalence OR per 100 mg of choline intake: 0.89; 95% CI: 0.77, 1.02; P < 0.10 for both total and dietary choline). No association was observed in men (n = 4479; P = 0.54 and 0.49 for total choline and dietary choline, respectively). Use of choline supplements was inversely associated with hypertension in both sexes (user compared with nonuser; OR: 0.68; 95% CI: 0.49, 0.92; P = 0.01). There was little to no association of total, dietary, or supplemental choline intake with systolic or diastolic BP (n = 6,554; the mean ± SEM change in BP associated with a 100-mg difference in total choline was -0.26 ± 0.22 mm Hg for systolic BP and -0.29 ± 0.19 mm Hg for diastolic BP).
CONCLUSIONS: Cross-sectional NHANES data do not support the hypothesis of a positive association between choline intake and BP.
© 2019 American Society for Nutrition.

Entities:  

Keywords:  NHANES; blood pressure; choline; hypertension; trimethylamine N-oxide

Year:  2019        PMID: 30831597     DOI: 10.1093/ajcn/nqy330

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  5 in total

1.  Choline Metabolites, Hydroxybutyrate and HDL after Dietary Fiber Supplementation in Overweight/Obese Hypertensive Women: A Metabolomic Study.

Authors:  Carla Patricia Novaes Dos Santos Fechine; Mussara Gomes Cavalcanti Alves Monteiro; Josean Fechine Tavares; Augusto Lopes Souto; Rafaella Cristhine Pordeus Luna; Cássia Surama Oliveira da Silva; Jairo Alves da Silva; Sócrates Golzio Dos Santos; Maria José de Carvalho Costa; Darlene Camati Persuhn
Journal:  Nutrients       Date:  2021-04-24       Impact factor: 5.717

2.  Association between dietary choline and betaine intake and 10.6-year cardiovascular disease in adults.

Authors:  Mahdieh Golzarand; Parvin Mirmiran; Fereidoun Azizi
Journal:  Nutr J       Date:  2022-01-05       Impact factor: 3.271

3.  Identification of Potential Metabolic Markers of Hypertension in Chinese Children.

Authors:  Jiahong Sun; Min Zhao; Liu Yang; Xue Liu; Lucia Pacifico; Claudio Chiesa; Bo Xi
Journal:  Int J Hypertens       Date:  2021-08-24       Impact factor: 2.420

4.  Association of Choline Intake with Blood Pressure and Effects of Its Microbiota-Dependent Metabolite Trimethylamine-N-Oxide on Hypertension.

Authors:  Guo-Dong He; Xiao-Cong Liu; An-Shang Lu; Ying-Qing Feng
Journal:  Cardiovasc Ther       Date:  2022-08-25       Impact factor: 3.368

5.  An untargeted metabolomics study of blood pressure: findings from the Bogalusa Heart Study.

Authors:  William J He; Changwei Li; Xuenan Mi; Mengyao Shi; Xiaoying Gu; Lydia A Bazzano; Alexander C Razavi; Jovia L Nierenberg; Kirsten Dorans; Hua He; Tanika N Kelly
Journal:  J Hypertens       Date:  2020-07       Impact factor: 4.844

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.